Search results
Biocon - Meeting Conducted With Institutional Investors/ Research Analysts
CNBC Awaaz· 10 hours agoBiocon - Meeting Conducted With Institutional Investors/ Research Analysts
Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you...
Livemint· 1 day agoDomestic equity benchmarks Sensex and Nifty 50 ended June with their best gain in 2024, boosted by...
Buy Biocon; target of Rs 400: Sharekhan
CNBC Awaaz· 11 hours agoSharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.
F&O stocks to buy today: ICICI Bank, Biocon among top 6 trading ideas for 27 June 2024
The Economic Times· 5 days agoExperts suggest buying opportunities in stocks like Indus Tower, ICICI Bank, Grasim Industries, and...
Stocks to buy: Federal Bank, Biocon, among top picks by SMC Global for this week
Livemint· 6 days agoNifty 50 closed 183 points, or 0.78 per cent, higher at 23,721.30, while the Sensex ended with a...
Nifty rides with bulls, can hit 24,600: Analysts
The Economic Times· 17 hours agoNifty could extend its gains as momentum remains strong with technical charts suggesting a positive bias. Analysts recommend stocks such as Reliance,...
Excited about gain in market share in US, says Biocon chief Kiran Mazumdar Shaw
The Economic Times· 6 days agoWanted to begin by asking you about India because I think that is, of course, the biggest talking...
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check...
Livemint· 2 days agoDividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power,...
EMA Approves Biocon Biologics to Produce Biosimilar Bevacizumab - India Telecom News
India Telecom News· 7 days agoIn Short:Biocon Biologics, a subsidiary of Biocon Ltd, has gotten approval from the European Medicines Agency to produce biosimilar Bevacizumab, a cancer ...
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 3 days agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...